Dr. Moshe Baru
KAHR Medical Ltd
Before joining KAHR Medical in 2014, Dr. Baru lead drug development at Omri Laboratories for 17 years. At Omri he lead the development of LongAte, a plasma derived Factor-8 formulated with liposomes, from concept to the market place. Moshe received his doctorate from The Technion, Israel Institute of Technology.